ArticleTherapeutic advances in medical oncology2024

French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel

Amaury Demaziere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.